COMMUNIQUÉS West-GlobeNewswire

ICC Labs Announces Its First Presale Agreement of CBD/THC Extracts and CBD/THC Oils for Distribution in Colombia

05/06/2018 - 14:34

Highlights: ICC Labs enters into its first CBD/THC presale agreement in Colombia. Colombia is the third country in the Latin American market where ICC Labs has now taken steps to commence sales, after México and Brazil [...]

Oxford Immunotec Applauds Updated Guidelines from the American Academy of Pediatrics Supporting Expanded Use of the T-SPOT®.TB Test

05/06/2018 - 14:30

OXFORD, United Kingdom and MARLBOROUGH, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that it applauds updated guidelines [...]

Radius to Host Investor Day on June 8, 2018

05/06/2018 - 14:30

Advancing Treatment Care for Osteoporosis WALTHAM, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announced today that it will host an Investor Day on Friday, June 8, 2018 in New York City [...]

OpGen’s Acuitas® AMR Gene Panel u5.47 Data to be Presented at ASM Microbe 2018

05/06/2018 - 14:30

Company Sponsors Symposium on Rapid Pathogen Detection and Prediction of Antimicrobial Resistance in Urinary Tract Infections GAITHERSBURG, Md., June 05, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today [...]

Ritter Pharmaceuticals Highlights Key Phase 2b Clinical Trial Data of RP-G28 for Lactose Intolerance at Digestive Disease Week 2018

05/06/2018 - 14:30

Additional Data Describes Novel Clinical Symptom Assessment Tool Developed in Phase 2b Trial and to be Used in Upcoming Phase 3 Clinical Trial LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc [...]

TESARO Announces Collaboration to Evaluate ZEJULA® in Combination With Anti-PD-L1 Cancer Immunotherapy and MEK Inhibitor in Platinum-Sensitive Ovarian Cancer

05/06/2018 - 14:30

WALTHAM, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that it has entered into a clinical collaboration with Genentech, a member of [...]

Sarepta Therapeutics to Present at Two Upcoming Investor Conferences

05/06/2018 - 14:30

CAMBRIDGE, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat [...]

LIDDS receives patent approval in Europe

05/06/2018 - 14:16

The European patent office has approved LIDDS' patent related to devices and methods of injection. The patent is now approved in all major markets and provides protection for all drug formulations based on the NanoZolid [...]

GTX Corp Announces New GPS Take-Along World Tracker for $89.00

05/06/2018 - 14:14

LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), an IoT platform and global provider of GPS tracking and monitoring wearable and wandering assistive technology, announced today the launch of its new [...]

PositiveID CSO and Former DHS Chief Scientist Calls for “Nunn-Lugar Act 2.0” to Dismantle Unprecedented Chemical and Biological Weapons Stockpile in North Korea

05/06/2018 - 14:05

“Two Minutes to Doomsday” article views North Korea’s chemical and biological weapons as greater threat than nuclear DELRAY BEACH, Fla., June 05, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company [...]

Milestone Scientific Features CompuFlo® Epidural System at Euroanaesthesia 2018

05/06/2018 - 14:02

Multiple abstracts presented at scientific poster session LIVINGSTON, N.J., June 05, 2018 (GLOBE NEWSWIRE) -- Milestone Scientific Inc . (NYSE:MLSS), a leading developer of computerized drug delivery instruments that [...]

Cognition Therapeutics Initiates NIA-Funded SNAP Study of Elayta™ to Measure Toxic Oligomer Displacement and Clearance in Alzheimer's Disease

05/06/2018 - 14:02

Pittsburgh, June 05, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and other [...]

Endocyte Announces Enrollment of First Patient in Phase 3 VISION Trial of 177Lu-PSMA-617 in Prostate Cancer

05/06/2018 - 14:01

Additional data from phase 2 investigator-initiated trial of 177Lu-PSMA-617 presented at American Society of Clinical Oncology (ASCO) WEST LAFAYETTE, Ind., June 05, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT [...]

Progressive Care Installs New TCGRx Pouch Packaging System in Miami

05/06/2018 - 14:00

Leading Florida-Based Healthcare Services and Technology Company Continues Expansion of Robot Pharmacy Machinery Fleet MIAMI, June 05, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized [...]

Spero Therapeutics to Present New Preclinical Data for SPR994 at ASM Microbe 2018

05/06/2018 - 14:00

Eighteen presentations with data across multiple pipeline candidates including data supporting SPR994’s broad spectrum of activity and equivalence to IV carbapenems CAMBRIDGE, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- [...]

B-Temia to Showcase Keeogo at G7 Summit

05/06/2018 - 14:00

B-Temia / Keeogo invited to G7 Summit Innovation Experience QUÉBEC CITY, June 05, 2018 (GLOBE NEWSWIRE) -- B-Temia Inc., a Canadian biorobotic tech company based in Quebec City and leader in the human mobility market is [...]

B-Temia présente le Keeogo au sommet du G7

05/06/2018 - 14:00

B-Temia / Keeogo est invité à l’Expérience Innovation du Sommet du G7 QUÉBEC, 05 juin 2018 (GLOBE NEWSWIRE) -- B-Temia Inc., une entreprise canadienne de technologie biorobotique basée à Québec et leader sur le marché [...]

Caladrius Biosciences Sells Rights to Counter-Flow Centrifugation System to Hitachi Chemical Advanced Therapeutics Solutions

05/06/2018 - 14:00

Sale of non-core asset brings $2.5 million in non-dilutive funding BASKING RIDGE, N.J., June 05, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq:CLBS) (“Caladrius” or the “Company”), a clinical-stage [...]

CareDx Promotes Living Donor Transplantation Through Employee Policy

05/06/2018 - 14:00

The progressive CareDx Living Donor Employee Recovery Policy announced at ATC BRISBANE, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, [...]